Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DEAD-box helicase 54 (DDX54) is an ATP-dependent RNA helicase belonging to the DEAD-box protein family, characterized by the conserved Asp-Glu-Ala-Asp (DEAD) motif[1][5]. It participates in alteration of RNA secondary structure, including processes such as translation initiation, splicing, and ribosome and spliceosome assembly[1][2]. DDX54 plays a crucial role in ribosome biogenesis, particularly in remodeling rRNA secondary structures during 60S ribosomal subunit formation and is essential for establishing the peptidyl transferase center in ribosomes[2]. The protein can also repress the transcriptional activity of nuclear receptors, functioning as a transcriptional corepressor[3][5]. DDX54 is implicated in cellular processes related to cell proliferation, differentiation, and apoptosis, and its dysfunction is associated with diseases such as renal hypoplasia, duodenum adenoma, and potentially cancer[1]. There is currently no evidence for direct drug interactions or use as a specific biomarker[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DEAD-box helicase 54 (DDX54).